Abstract
This statement paper deals with the key role an neurologist plays in the management of victims of chemical warfare/terrorist attacks. Because terrorist factions have expanded the war zone creating a worldwide risk of terrorist attacks, not only limited to some conflict zones in the Middle East, neurologists in all countries/regions have to be prepared for disaster response. The scope of this paper is to provide guidelines for the neurological management of victims of chemical and biological terrorist attacks.
Similar content being viewed by others
References
De Cauwer H, Somville F, Sabbe M, Mortelmans LJ (2017) Hospitals: soft target for terrorism? Prehospital disaster medicine. Prehosp Disaster Med 32(1):94–100
Bommen Zaventem bevatten spijkers. http://www.hln.be/hln/nl/957/Binnenland/article/detail/2654459/2016/03/22/Bommen-Zaventem-bevatten-spijkers.dhtml. Assessed 4th July 2016
Foreign Press Center Briefing: Preview of the 2016 Nuclear Security Summit. http://www.nss2016.org/news/2016/3/30/fpc-briefing-3-29-16. Assessed 4th July 2016
Okudera H, Morita H, Iwashita T, Shibata T, Otagiri T, Kobayashi S, Yanagisawa N (1997) Unexpected nerve gas exposure in the city of Matsumoto: report of rescue activity in the first sarin gas terrorism. Am J Emerg Med 15(5):527–528
Asai Y, Arnold JL (2003) Terrorism in Japan. Prehosp Disaster Med 18(2):106–114
Terrorism in the United States. https://en.wikipedia.org/wiki/Terrorism_in_the_United_States. Assessed 4th July 2016
Mortelmans LJ, Van Boxstael S, De Cauwer HG, Sabbe MB (2014) Belgian Society of Emergency and Disaster Medicine (BeSEDiM) study. Preparedness of Belgian civil hospitals for chemical, biological, radiation, and nuclear incidents: are we there yet? Eur J Emerg Med 21(4):296–300
CDC Working Group (2000) Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 49:1–14
Barras V, Greub G (2014) History of biological warfare and bioterrorism. Clin Microbiol Infect 20(6):497–502
Cenciarelli O, Gabbarini V, Pietropaoli S, Malizia A, Tamburrini A, Ludovici GM et al (2015) Viral bioterrorism: Learning the lesson of Ebola virus in West Africa 2013–2015. Virus Res 210:318–326
Bus KM, Bleck TP (2012) Treatment of neuroterrorism. Neurotherapeutics. 9(1):139–157
Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH (1993) Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA 90(6):2291–2294
Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M et al (2001) Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 7(6):933–944
Revich BA, Podolnaya MA (2011) Thawing of permafrost may disturb historic cattle burial grounds in East Siberia. Glob Health Action. doi:10.3402/gha.v4i0.8482
Anthrax outbreak triggered by climate change kills boy in Arctic Circle. https://www.theguardian.com/world/2016/aug/01/anthrax-outbreak-climate-change-arctic-circle-russia. Assessed 31 Aug 2016
Bush LM, Abrams BH, Beall A, Johnson CC (2001) Index case of fatal inhalation anthrax due to bioterrorism in the United States. N Engl J Med 345:1607–1610
Lanska DJ (2002) Anthrax meningoencephalitis. Neurology 59:327–334
Kim HJ, Jun WB, Lee SH, Rho MH (2001) CT and MR findings of anthrax meningoencephalitis: report of two cases and review of the literature. AJNR Am J Neuroradiol 22:1303–1305
Sejvar JJ, Tenover FC, Stephens DS (2005) Management of anthrax meningitis. Lancet Infect Dis 5(5):287–295
Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM et al (1999) Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281(18):1735–1745
Dixon TC, Meselson M, Guillemin J, Hanna PC (1999) Anthrax. N Engl J Med 341:815–826
Bower WA, Hendricks K, Pillai S, Guarnizo J, Meaney-Delman D (2015) Centers for Disease Control and Prevention (CDC). Clinical framework and medical countermeasure use during an anthrax mass-casualty incident. MMWR Recomm Rep 64(4):1–22
Katharios-Lanwermeyer S, Holty JE, Person M, Sejvar J, Haberling D, Tubbs H et al (2016) Identifying meningitis during an anthrax mass casualty incident: systematic review of systemic anthrax since 1880. Clin Infect Dis 62(12):1537–1545
Erbguth FJ (2004) Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 19(Suppl 8):S2–S6
Caya JG, Agni R, Miller JE (2004) Clostridium botulinum and the clinical laboratorian: a detailed review of botulism, including biological warfare ramifications of botulinum toxin. Arch Pathol Lab Med 128(6):653–662
Panicker JN, Muthane UB (2003) Botulinum toxins: pharmacology and its current therapeutic evidence for use. Neurol India 51(4):455–460
Franz DR, Jahrling PB, Friedlander AM et al (1997) Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278:399–411
Martin CO, Adams HP Jr (2003) Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch Neurol 60:21–25
Arnon SS, Schechter R, Inglesby TV et al (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059–1070
Noguchi T, Onuki K, Arakawa O (2011) Tetrodotoxin poisoning due to pufferfish and gastropods, and their intoxication mechanism. ISRN Toxicol 2011:276939
Turner AD, Higgins C, Higman W, Hungerford J (2015) Potential threats posed by tetrodotoxins in UK waters: examination of detection methodology used in their control. Mar Drugs 13(12):7357–7376
Food Safety Agency seeks to avert mussel scare. http://deredactie.be/cm/vrtnieuws.english/Health%2Band%2BEnvironment/1.2696432. Assessed 21 August 2016
Cole JB, Heegaard WG, Deeds JR, McGrath SC, Handy SM (2015) Centers for Disease Control and Prevention (CDC). Tetrodotoxin poisoning outbreak from imported dried puffer fish–Minneapolis, Minnesota, 2014. MMWR Morb Mortal Wkly Rep 63(51):1222–1225
Bane V, Lehane M, Dikshit M, O’Riordan A, Furey A (2014) Tetrodotoxin: chemistry, toxicity, source, distribution and detection. Toxins (Basel) 6(2):693–755
Hajra A, Bandyopadhyay D, Hajra SK (2016) Zika virus: a global threat to humanity: a comprehensive review and current developments. N Am J Med Sci 8(3):123–128
Centers for disease control and prevention. Transmission & risks. http://www.cdc.gov/zika/transmission/index.html. Assessed 05 Sept 2016
Broutet N, Krauer F, Riesen M, Khalakdina A, Almiron M, Aldighieri S et al (2016) Zika virus as a cause of neurologic disorders. N Engl J Med 374(16):1506–1509
Petersen EE, Staples JE, Meaney-Delman D, Fischer M, Ellington SR, Callaghan WM et al (2016) Interim guidelines for pregnant women during a Zika virus outbreak-United States, 2016. MMWR Morb Mortal Wkly Rep 65:30–33
Baldacchino F, Caputo B, Chandre F, Drago A, Della Torre A, Montarsi F, Rizzoli A (2015) Control methods against invasive Aedes mosquitoes in Europe: a review. Pest Manag Sci 71(11):1471–1485
Scholte E, Den Hartog W, Dik M, Schoelitsz B, Brooks M, Schaffner F, Foussadier R, Braks M, Beeuwkes J (2010) Introduction and control of three invasive mosquito species in the Netherlands, July–October 2010. Euro Surveill 15(45)
Brown CM, Aranas AE, Benenson GA, Brunette G, Cetron M, Chen TH et al (2014) Centers for Disease Control and Prevention (CDC). Airport exit and entry screening for Ebola—August–November 10, 2014. MMWR Morb Mortal Wkly Rep 63(49):1163–1167
Strauss S (2014) Ebola research fueled by bioterrorism threat. CMAJ 186(16):1206
Bray M (2003) Defense against filoviruses used as biological weapons. Antiviral Res 57(1–2):53–60
Cenciarelli O, Gabbarini V, Pietropaoli S, Malizia A, Tamburrini A, Ludovici GM et al (2015) Viral bioterrorism: Learning the lesson of Ebola virus in West Africa 2013–2015. Virus Res 210:318–326
Dvorin, T. (2014). Could ISIS target the West with Ebola? Arutz Sheva. IsraelNational News. http://www.israelnationalnews.com/News/News.aspx/186020#.VDvayfldWSo. Assessed 22 Aug 2016
Unieke videobeelden hoe ebola ontdekt werd. http://www.hln.be/hln/nl/957/Binnenland/article/detail/2096411/2014/10/21/Unieke-videobeelden-hoe-ebola-ontdekt-werd.dhtml. Assessed 5 Sept 2016
Rosello A, Mossoko M, Flasche S, Van Hoek AJ, Mbala P, Camacho A et al (2015) Ebola virus disease in the Democratic Republic of the Congo, 1976–2014. eLife 4:e09015
Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA et al (2015) Transmission of Ebola viruses: what we know and what we do not know. MBio 6(2):e00137
Jacobs M, Rodger A, Bell DJ, Bhagani S, Cropley I, Filipe A et al. (2016) Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 30(388):498–503
Howlett P, Brown C, Helderman T, Brooks T, Lisk D, Deen G, Solbrig M, Lado M, Leone S (2016) Ebola virus disease complicated by late-onset encephalitis and polyarthritis. Emerg Infect Dis 22(1):150–152
Jacob H (1971) The neuropathology of the Marburg disease in man. In: Martini GA, Siegert R (eds) Marburg virus disease. Springer, Berlin, pp P54–P61
Fitzgerald GJ (2008) Chemical warfare and medical response during World War I. Am J Public Health 98(4):611–625
Moshiri M, Darchini-Maragheh E, Balali-Mood M (2012) Advances in toxicology and medical treatment of chemical warfare nerve agents. Daru 20(1):81
Weissman BA, Raveh L (2011) Multifunctional drugs as novel antidotes for organophosphates’ poisoning. Toxicology 290(2–3):149–155
Balali-Mood M, Balali-Mood K (2008) Neurotoxic disorders of organophosphorus compounds and their managements. Arch Iran Med 11(1):65–89
Raveh L, Eisenkraft A, Weissman BA (2014) Caramiphen edisylate: an optimal antidote against organophosphate poisoning. Toxicology 325:115–124
Cannard K (2006) The acute treatment of nerve agent exposure. J Neurol Sci 249(1):86–94
Mercey G, Verdelet T, Renou J, Kliachyna M, Baati R, Nachon F, Jean L, Renard PY (2012) Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Acc Chem Res 45(5):756–766
Aracava Y, Pereira EF, Akkerman M, Adler M, Albuquerque EX (2009) Effectiveness of donepezil, rivastigmine, and (±)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine. J Pharmacol Exp Ther 331(3):1014–1024
Lavon O, Eisenkraft A, Blanca M, Raveh L, Ramaty E, Krivoy A et al (2015) Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers. Neurotoxicology 49:36–44
Marrs TC (2004) The role of diazepam in the treatment of nerve agent poisoning in a civilian population. Toxicol Rev 23(3):145–157
Gilat E, Kadar T, Levy A, Rabinovitz I, Cohen G, Kapon Y et al (2005) Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an electrographic, behavioral, and histological study in freely moving rats. Toxicol Appl Pharmacol 209(1):74–85
Heffernan R, Mostashari F, Das D, Besculides M, Rodriguez C, Greenko J et al (2004) New York City syndromic surveillance systems. MMWR Suppl 53:23–27
Das D, Weiss D, Mostashari F, Treadwell T, McQuiston J, Hutwagner L et al (2003) Enhanced drop-in syndromic surveillance in New York City following September 11, 2001. J Urban Health 80(2 Suppl 1):i76–i88
Donaghy M (2006) Neurologists and the threat of bioterrorism. J Neurol Sci 249:55–62
Casebeer L, Andolsek K, Abdolrasulnia M, Green J, Weissman N, Pryor E et al (2006) Evaluation of an online bioterrorism continuing medical education course. J Contin Educ Health Prof 26(2):137–144
Cosgrove SE, Perl TM, Song X, Sisson SD (2005) Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Arch Intern Med 165(17):2002–2006
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors report no disclosure nor conflict of interest relevant to the manuscript. All authors report no financial disclosure.
Ethical approval
This manuscript does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
None.
Rights and permissions
About this article
Cite this article
De Cauwer, H., Somville, F.J.M.P. & Joillet, M. Neurological aspects of chemical and biological terrorism: guidelines for neurologists. Acta Neurol Belg 117, 603–611 (2017). https://doi.org/10.1007/s13760-017-0774-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-017-0774-y